Logo image of NZP.CA

CHATHAM ROCK PHOSPHATE LTD (NZP.CA) Stock Fundamental Analysis

Canada - TSX-V:NZP - CA1621631094 - Common Stock

0.04 CAD
+0 (+14.29%)
Last: 9/24/2025, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, NZP scores 1 out of 10 in our fundamental rating. NZP was compared to 30 industry peers in the Chemicals industry. While NZP seems to be doing ok healthwise, there are quite some concerns on its profitability. NZP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NZP has reported negative net income.
NZP had negative earnings in each of the past 5 years.
NZP had a negative operating cash flow in each of the past 5 years.
NZP.CA Yearly Net Income VS EBIT VS OCF VS FCFNZP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 -500K -1M -1.5M -2M

1.2 Ratios

NZP has a Return On Assets of -17.20%. This is in the lower half of the industry: NZP underperforms 60.00% of its industry peers.
The Return On Equity of NZP (-18.26%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -17.2%
ROE -18.26%
ROIC N/A
ROA(3y)-20.3%
ROA(5y)-16.92%
ROE(3y)-21.69%
ROE(5y)-18.17%
ROIC(3y)N/A
ROIC(5y)N/A
NZP.CA Yearly ROA, ROE, ROICNZP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NZP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NZP.CA Yearly Profit, Operating, Gross MarginsNZP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100K -200K -300K -400K

More info and screens

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, NZP has more shares outstanding
The number of shares outstanding for NZP has been increased compared to 5 years ago.
NZP has a better debt/assets ratio than last year.
NZP.CA Yearly Shares OutstandingNZP.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NZP.CA Yearly Total Debt VS Total AssetsNZP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

2.2 Solvency

NZP has an Altman-Z score of -1.52. This is a bad value and indicates that NZP is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.52, NZP is doing worse than 60.00% of the companies in the same industry.
NZP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.52
ROIC/WACCN/A
WACCN/A
NZP.CA Yearly LT Debt VS Equity VS FCFNZP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M 6M

2.3 Liquidity

A Current Ratio of 0.21 indicates that NZP may have some problems paying its short term obligations.
NZP has a worse Current ratio (0.21) than 76.67% of its industry peers.
A Quick Ratio of 0.21 indicates that NZP may have some problems paying its short term obligations.
NZP has a worse Quick ratio (0.21) than 76.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.21
NZP.CA Yearly Current Assets VS Current LiabilitesNZP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

NZP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.29%, which is quite impressive.
EPS 1Y (TTM)34.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.86%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NZP.CA Yearly Revenue VS EstimatesNZP.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 1K 2K 3K 4K 5K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NZP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NZP.CA Price Earnings VS Forward Price EarningsNZP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NZP.CA Per share dataNZP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NZP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHATHAM ROCK PHOSPHATE LTD

TSX-V:NZP (9/24/2025, 7:00:00 PM)

0.04

+0 (+14.29%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)09-08 2025-09-08
Earnings (Next)03-02 2026-03-02
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.9%
Ins Owner ChangeN/A
Market Cap4.38M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.2%
ROE -18.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-20.3%
ROA(5y)-16.92%
ROE(3y)-21.69%
ROE(5y)-18.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.21
Altman-Z -1.52
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A